[Oral treatment of diabetes mellitus with the new sulfonylurea tolazamide].
D000328:Adult; D000368:Aged; D001645:Biguanides / Q000008:administration & dosage / Q000627:therapeutic use*; D001786:Blood Glucose / Q000032:analysis; D003864:Depression, Chemical; D003920:Diabetes Mellitus / Q000097:blood / Q000188:drug therapy*; D005260:Female; D006801:Humans; D007004:Hypoglycemic Agents / Q000627:therapeutic use*; D007328:Insulin / Q000008:administration & dosage / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D014042:Tolazamide / Q000009:adverse effects / Q000627:therapeutic use; D014508:Urea / Q000627:therapeutic use*
D001645:Biguanides; D001786:Blood Glucose; D007004:Hypoglycemic Agents; D007328:Insulin; D014508:Urea; D014042:Tolazamide
Die orale Behandlung des Diabetes mellitus mit dem neuen Sulfonylharmstoff Tolazamid.